Buy Divi’s Laboratories; target of Rs 1800: Sharekhan

Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated August 14, 2019.

Broker Research

August 19, 2019 / 15:50 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Sharekhan's research report on Divi’s Laboratories

Divis Laboratories Limited’s (Divis) quarterly performance was marginally below our expectation. Growth outlook intact, capex to weigh on margins in FY2020, no pending regulatory hurdles. We expect the company to a report sales/profit CAGR of 21%/18% over FY2019-FY2021.

Outlook

We maintain our Buy rating on the stock with marginally lowered PT of Rs. 1,800.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

first published: Aug 19, 2019 03:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347